NCP MP raises concern over rare diseases, says no patient has benefited from new policy

She alleged that the ‘unending delay and lack of urgency’ has claimed several young lives and endangered the survival prospects of 415 patients

December 13, 2022 03:14 am | Updated 03:14 am IST - CHENNAI

Fauzia Khan. File

Fauzia Khan. File | Photo Credit: PTI

Rajya Sabha MP from the Nationalist Congress Party Fauzia Khan on Friday raised concerns over the benefits of the National Policy of Rare Diseases (NPRD) not reaching any patient with rare diseases even after several months since its introduction.

The Union Ministry of Health and Family Welfare notified the NPRD in March 2021. In May, it increased the funding support to ₹50 lakh per patient with diseases classified as rare for their treatment.

However, the MP alleged that the “unending delay and lack of urgency” on the part of the Centres of Excellence (CoE), designated as per the policy, has claimed several young lives and endangered the survival prospects of 415 patients, largely children, diagnosed with rare diseases.

These diseases included Lysosomal storage disorders, Gaucher disease, Pompe disease, MPS 1 and 2 and Fabry disease. An analysis of data from the national crowd-funding platform revealed that around 190 patients diagnosed with ultra-rare genetic conditions could be immediately put on life-saving therapy, she added.

She said that majority of these patients have been diagnosed with Gaucher disease, for which therapy approved by Drug Controller General of India is available for many years. She pointed out that many CoEs were yet to seek financial support as per the policy for treating the patients. She urged the Ministry to issue urgent instructions to all the CoEs to commence treatment for these patients.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.